These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16202916)

  • 1. Inaccuracy of coagulation studies performed on blood samples obtained from arterial catheter.
    Akinci SB; Salman N; Aykut T; Kanbak M; Aypar U
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):702-3. PubMed ID: 16202916
    [No Abstract]   [Full Text] [Related]  

  • 2. Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery: a comparative study.
    Leyvi G; Zhuravlev I; Inyang A; Vinluan J; Ramachandran S; Lehning EJ; Wasnick JD
    J Cardiothorac Vasc Anesth; 2004 Oct; 18(5):573-80. PubMed ID: 15578467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protamine dosing--the quandary continues.
    Hall RI
    Can J Anaesth; 1998 Jan; 45(1):1-5. PubMed ID: 9466018
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of heparin-coated pulmonary artery catheters on activated coagulation time in cardiac surgical patients.
    Haering JM; Maslow AD; Parker RA; Lowenstein E; Comunale ME
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):260-3. PubMed ID: 10890477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiopulmonary bypass and blood coagulation].
    Kitaguchi K; Furuie H
    Masui; 2001 Dec; 50 Suppl():S115-20. PubMed ID: 11871083
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk management in cardiac anesthesia: analysis of critical issues. Introduction.
    Ellison N; Pierce EC
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):1-2. PubMed ID: 9583567
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activated coagulation time during surgery with extracorporeal circulation].
    Piatnitskaia GKh; Khodaz MIa; Savina ME; Dement'eva II
    Anesteziol Reanimatol; 1991; (5):66-74. PubMed ID: 1767969
    [No Abstract]   [Full Text] [Related]  

  • 10. Low heparinization and heparin-bonded circuits.
    Hill RC
    Ann Thorac Surg; 1997 Oct; 64(4):1221-2. PubMed ID: 9354574
    [No Abstract]   [Full Text] [Related]  

  • 11. Con: Heparin-bonded cardiopulmonary bypass circuits should be routine for all cardiac surgical procedures.
    Taneja R; Cheng DC
    Anesth Analg; 2006 Dec; 103(6):1370-2. PubMed ID: 17122205
    [No Abstract]   [Full Text] [Related]  

  • 12. More biocompatibility in cardiopulmonary bypass for high-risk patients.
    Baufreton C
    Ann Thorac Surg; 2006 Feb; 81(2):790-1; author reply 791. PubMed ID: 16427917
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does preoperative level of antithrombin III predict heparin resistance during extracorporeal circulation?
    Rodríguez-López JM; del Barrio E; Lozano FS; Muriel C
    Anesth Analg; 2008 Oct; 107(4):1444-5. PubMed ID: 18806070
    [No Abstract]   [Full Text] [Related]  

  • 16. Pro: Is the pulmonary artery catheter dead?
    Ramsay J
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):144-6. PubMed ID: 17289498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin resistance associated with elevated factor VIII].
    Kumano N; Ikeda S; Arimori Y; Ono T; Saeki S
    Masui; 2008 Apr; 57(4):471-3. PubMed ID: 18416208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another bleeding heart: perioperative heparin management revisited.
    Harle CC; Murkin JM
    Can J Anaesth; 2007 Feb; 54(2):97-102. PubMed ID: 17272247
    [No Abstract]   [Full Text] [Related]  

  • 19. Con: Is the pulmonary artery catheter dead?
    Murphy GS; Vender JS
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):147-9. PubMed ID: 17289499
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiopulmonary support in the intensive care unit.
    Pritchard GL
    Am J Crit Care; 1993 Jan; 2(1):100-1. PubMed ID: 8353573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.